This product is a mucus regulator, which mainly acts on the secretion of bronchial glands, increasing the secretion of low-viscosity salivary mucin and reducing the production of high-viscosity fucoxomucin, thereby reducing the viscosity of sputum and making it easier to cough up. It takes effect quickly after oral administration, and obvious therapeutic effects can be seen within 4 hours of taking it.

This product is a broad-spectrum antifungal drug, and its mechanism of action is to inhibit the synthesis of fungal cell membranes and affect their metabolic processes. It has antibacterial effects on a variety of shallow and deep fungi.

This product is a broad-spectrum antifungal drug, and its mechanism of action is to inhibit the synthesis of fungal cell membranes and affect their metabolic processes. It has antibacterial effects on a variety of shallow and deep fungi.

This product is a broad-spectrum antifungal drug, and its mechanism of action is to inhibit the synthesis of fungal cell membranes and affect their metabolic processes. It has antibacterial effects on a variety of shallow and deep fungi.

This product is a broad-spectrum antifungal drug, and its mechanism of action is to inhibit the synthesis of fungal cell membranes and affect their metabolic processes. It has antibacterial effects on a variety of shallow and deep fungi.

This product is a broad-spectrum antifungal drug, and its mechanism of action is to inhibit the synthesis of fungal cell membranes and affect their metabolic processes. It has antibacterial effects on a variety of shallow and deep fungi.

This product is a broad-spectrum antifungal drug, and its mechanism of action is to inhibit the synthesis of fungal cell membranes and affect their metabolic processes. It has antibacterial effects on a variety of shallow and deep fungi.

This product is a broad-spectrum antifungal drug, and its mechanism of action is to inhibit the synthesis of fungal cell membranes and affect their metabolic processes. It has antibacterial effects on a variety of shallow and deep fungi.

This product is a broad-spectrum antifungal drug, and its mechanism of action is to inhibit the synthesis of fungal cell membranes and affect their metabolic processes. It has antibacterial effects on a variety of shallow and deep fungi.

This product is a broad-spectrum antifungal drug, and its mechanism of action is to inhibit the synthesis of fungal cell membranes and affect their metabolic processes. It has antibacterial effects on a variety of shallow and deep fungi.

This product is a broad-spectrum antifungal drug, and its mechanism of action is to inhibit the synthesis of fungal cell membranes and affect their metabolic processes. It has antibacterial effects on a variety of shallow and deep fungi.

Inhibits bacterial protein synthesis and has antibacterial effects on Gram-positive bacteria and Chlamydia trachomatis

Erythromycin is a macrolide antibiotic whose mechanism of action is to inhibit bacterial protein synthesis. It has antibacterial effects on Gram-positive bacteria and Chlamydia trachomatis.

Erythromycin is a macrolide antibiotic whose mechanism of action is to inhibit bacterial protein synthesis. It has antibacterial effects on Gram-positive bacteria and Chlamydia trachomatis.

This product is a synthetic nucleoside antiviral drug that can be selectively phosphorylated by the virus's thymidine kinase and converted into a monophosphate, which is then converted into a diphosphate and a triphosphate by the action of cellular enzymes. Acyclovir triphosphate can interfere with DNA polymerase, especially herpes virus DNA enzyme, thereby inhibiting the replication of viral DNA. In vivo and in vitro experiments have shown that acyclovir has an inhibitory effect on herpes simplex virus type Ⅰ (HSV-1), type Ⅱ (HSV-2) and varicella-zoster virus (VZV). Cell culture results show that this product has the strongest effect on inhibiting HSV-1 virus, followed by HSV-2 and VZV virus.

Tetracycline antibiotics. This product is a broad-spectrum antibacterial agent with bactericidal effects at high concentrations. Rickettsia, Mycoplasma, Chlamydia, atypical mycobacteria, and spirochetes are also sensitive to this product. This product is more effective against Gram-positive bacteria than Gram-negative bacteria, but Enterococcus is resistant to it. Others such as Actinomycetes, Bacillus anthracis, Listeria monocytogenes, Clostridium, Nocardia, Vibrio, Brucella, Campylobacter, and Yersinia are sensitive to this product. This product has certain antibacterial activity against Neisseria gonorrhoeae, but penicillin-resistant Neisseria gonorrhoeae is also resistant to doxycycline. Due to the widespread use of tetracyclines over the years, common clinical pathogens have become seriously resistant to this product, including Gram-positive bacteria such as Staphylococcus and most Gram-negative bacilli.